$PSTV 🧬 Due Diligence Company: Plus Therapeutics Inc. (NASDAQ: PSTV) Sector: Biotechnology (focus on cancer therapies) Recent Catalysts: Clinical trial results for a new cancer treatment Strategic partnership with a major pharma company Financial restructuring to improve cash flow Technical Setup: Recently crossed above 20-day moving average Support: $0.32, $0.29 Resistance: $0.42, $0.50, $0.65 🔥 Short Interest & Float Short Interest: 5.74 million shares Short % of Float: 9.5% Shares Outstanding: ~17 million Float: ~14 million 2 Borrow Fee Rate: ~100%+ APR — very high, indicating strong short pressure and squeeze potential